Related Experiment Video
Updated: Jul 9, 2026

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
Prostaglandin E2: making more of your marrow
Allegra M Lord1, Trista E North, Leonard I Zon
1Stem Cell Program and Hematology/Oncology, Children's Hospital and Dana- Farber Cancer Institute, HHMI, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Prostaglandin E2 (PGE2) regulates hematopoietic stem cell (HSC) number across species. PGE2 may expand HSCs for improved transplantation outcomes after chemotherapy or irradiation.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunology
Background:
- Prostaglandin E2 (PGE2) is identified as a key regulator of hematopoietic stem cell (HSC) number.
- Evidence from zebrafish and murine models supports PGE2's conserved role in hematopoiesis.
Purpose of the Study:
- To summarize the current understanding of PGE2's role in blood cell homeostasis.
- To discuss the potential clinical applications of PGE2 for hematopoietic stem cell expansion in transplantation.
Main Methods:
- Chemical screening in zebrafish embryos.
- In vitro and in vivo studies in murine models.
Main Results:
- PGE2 was confirmed as an evolutionarily conserved regulator of HSC number.
- Bioactive PGE2 derivatives show promise for accelerating hematopoietic recovery.
Conclusions:
- PGE2 influences blood cell homeostasis.
- PGE2 holds potential for ex vivo HSC expansion to enhance transplantation success.
More Related Videos
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
10:03Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Erythropoiesis
Erythropoiesis
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Regulation of Hematopoietic Stem Cells